Final answer:
Cutaneous amyloidosis typically presents with hypopigmented skin, skin lesions, and nodules, and may lead to loss of peripheral nerve function and extremities. Systemic symptoms like nausea and confusion are not directly associated with cutaneous amyloidosis, but rather with systemic conditions like SLE. Correct diagnosis is crucial for proper management.
Step-by-step explanation:
Clinical Features of Cutaneous Amyloidosis The clinical features of cutaneous amyloidosis include a range of symptoms that affect the skin and may have systemic implications. Commonly observed signs include hypopigmented skin, the presence of skin lesions, and the formation of nodules. In some more severe cases, there can be loss of peripheral nerve function which may lead to the loss of fingers, toes, and extremities. Although not directly related to cutaneous amyloidosis, symptoms such as nausea, vomiting, photophobia, stiff neck, confusion, fatigue, fever, joint pain and swelling, hair loss, anemia, clotting, and a sunlight-sensitive 'butterfly' rash are indicative of systemic involvement that may accompany skin changes in different conditions such as systemic lupus erythematosus (SLE). It is important to distinguish between cutaneous amyloidosis and SLE, as treatment and prognosis differ significantly.